nach oben

Erschienen in:

06.09.2021 | Original Article

Epidemiology, management and outcome of status epilepticus in adults: single-center Italian survey

verfasst von: Carlotta Mutti, Angelo Sansonetti, Giampiero Monti, Claudia Vener, Irene Florindo, Anna Elisabetta Vaudano, Irene Trippi, Giorgia Bernabè, Liborio Parrino, Lucia Zinno

Erschienen in: Neurological Sciences | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

The official variations of status epilepticus (SE) International League Against Epilepsy (ILAE, 2015) diagnostic criteria and the non-convulsive SE (NCSE) Salzburg Consensus Criteria (2013), impose the collection of updated population-based epidemiological Italian data. In this study, we aimed at evaluating (a) the frequency of SE in our hospital adopting the new ILAE 2015 SE diagnostic criteria and NCSE Salzburg Consensus Criteria, (b) the frequency of adherence to current treatment guidelines for SE and their relationship with patients’ outcome, and (c) reliability of standardized prognostic scales (Status Epilepticus Severity Score—STESS—and modified STESS) for short-term outcome prediction in the setting of the newest diagnostic criteria for SE and NCSE. Detailed clinical and electrophysiological data collected in a 1-year retrospective hospital-based single-center survey on SE at Parma Hospital, Northern Italy are provided. Non-adherence to current treatment guidelines was recorded in around 50% cases, but no relation to outcome was appreciated. Mortality in our cohort increased from 30 to 50% when follow-up was extended to 30 days. STESS score was strongly correlated with short-term mortality risk (OR 18.9, 2.2–163.5, CI), and we confirm its role as easy-to-use tool for outcome evaluation also when the new ILAE diagnostic SE criteria are applied.

Logroscino G, Hesdorffer DC, Cascino G, Hauser WA, Coeytaux A, Galobardes B et al (2005) Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia 46(Suppl 11):46–48. https://doi.org/10.1111/j.1528-1167.2005.00409.xCrossRefPubMed

Vignatelli L, Rinaldi R, Galeotti M, de Carolis P, D’Alessandro R (2005) Epidemiology of status epilepticus in a rural area of northern Italy: a 2-year population-based study. Eur J Neurol 12(11):897–902. https://doi.org/10.1111/j.1468-1331.2005.01073.xCrossRefPubMed

Vignatelli L, Tonon C, D’Alessandro R, Bologna Group for the Study of Status Epilepticus (2003) Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 44(7):964–8. https://doi.org/10.1046/j.1528-1157.2003.63702.xCrossRefPubMed

Coeytaux A, Jallon P, Galobardes B, Morabia A (2000) Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 55(5):693–697. https://doi.org/10.1212/wnl.55.5.693CrossRefPubMed

DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG (1995) Epidemiology of status epilepticus. J Clin Neurophysiol 12(4):316–325CrossRef

Hauser WA (1990) Status epilepticus: epidemiologic considerations. Neurology 40(5 Suppl 2):9–13PubMed

Szucs A, Barcs G, Jakus R, Rásonyi G, Lalit N, Holló A et al (2008) Late-life absence status epilepticus: a female disorder? Epileptic Disord 10(2):156–161. https://doi.org/10.1684/epd.2008.0186CrossRefPubMed

Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA (1997) Short-term mortality after a first episode of status epilepticus. Epilepsia 38(12):1344–1349. https://doi.org/10.1111/j.1528-1157.1997.tb00073.xCrossRefPubMed

Atmaca MM, Bebek N, Baykan B, Gökyiğit A, Gürses C (2017) Predictors of outcomes and refractoriness in status epilepticus: a prospective study. Epilepsy Behav 75:158–164. https://doi.org/10.1016/j.yebeh.2017.07.046CrossRefPubMed

10.

Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB (2006) Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 77(5):611–615. https://doi.org/10.1136/jnnp.2005.080887CrossRefPubMedPubMedCentral

11.

Spatola M, Alvarez V, Rossetti AO (2013) Benzodiazepine overtreatment in status epilepticus is related to higher need of intubation and longer hospitalization. Epilepsia 54(8):e99–e102. https://doi.org/10.1111/epi.12235CrossRefPubMed

12.

Scholtes FB, Renier WO, Meinardi H (1994) Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients. Epilepsia 35(5):1104–12. https://doi.org/10.1111/j.1528-1157.1994.tb02562.xCrossRefPubMed

13.

Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J et al (2016) Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr 16(1):48–61. https://doi.org/10.5698/1535-7597-16.1.48CrossRefPubMedPubMedCentral

14.

Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB (2008) Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 255(10):1561–1566. https://doi.org/10.1007/s00415-008-0989-1CrossRefPubMed

15.

González-Cuevas M, Santamarina E, Toledo M, Quintana M, Sala J, Sueiras M, Guzman L et al (2016) A new clinical score for the prognosis of status epilepticus in adults. Eur J Neurol 23(10):1534–1540. https://doi.org/10.1111/ene.13073CrossRefPubMed

16.

Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S et al (2015) A definition and classification of status epilepticus–report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 56(10):1515–1523. https://doi.org/10.1111/epi.13121CrossRefPubMed

17.

Hirsch LJ, LaRoche SM, Gaspard N, Gerard E, Svoronos A, Herman ST et al (2013) American Clinical Neurophysiology Society’s Standardized Critical Care EEG Terminology: 2012 version. J Clin Neurophysiol 30(1):1–27. https://doi.org/10.1097/WNP.0b013e3182784729CrossRefPubMed

18.

Trinka E, Leitinger M (2015) Which EEG patterns in coma are nonconvulsive status epilepticus? Epilepsy Behav 49:203–222. https://doi.org/10.1016/j.yebeh.2015.05.005CrossRefPubMed

19.

Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E et al (2015) Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus–approach to clinical application. Epilepsy Behav 49:158–163. https://doi.org/10.1016/j.yebeh.2015.05.007CrossRefPubMed

20.

Ferlisi M, Shorvon S (2012) The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 135(Pt 8):2314–28. https://doi.org/10.1093/brain/aws091. Epub 2012 May 9. Erratum in: Brain. 2013 Jul;136(Pt 7):2326

21.

Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A et al (2019) Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia 60(1):53–62. https://doi.org/10.1111/epi.14607CrossRefPubMed

22.

Tanaka T, Ihara M (2017) Post-stroke epilepsy. Neurochem Int 107:219–228. https://doi.org/10.1016/j.neuint.2017.02.002CrossRefPubMed

23.

Santarone ME, Pietrafusa N, Fusco L (2020) Neonatal seizures: when semiology points to etiology. Seizure 80:161–165. https://doi.org/10.1016/j.seizure.2020.06.025CrossRefPubMed

24.

Sutter R, Rüegg S, Kaplan PW (2012) Epidemiology, diagnosis, and management of nonconvulsive status epilepticus: opening Pandora’s box. Neurol Clin Pract 2(4):275–286. https://doi.org/10.1212/CPJ.0b013e318278be75CrossRefPubMedPubMedCentral

25.

Koren JP, Herta J, Pirker S, Fürbass F, Hartmann M, Kluge T et al (2016) Rhythmic and periodic EEG patterns of ‘ictal-interictal uncertainty’ in critically ill neurological patients. Clin Neurophysiol 127(2):1176–1181. https://doi.org/10.1016/j.clinph.2015.09.135CrossRefPubMed

26.

Punia V, Garcia CG, Hantus S (2015) Incidence of recurrent seizures following hospital discharge in patients with LPDs (PLEDs) and nonconvulsive seizures recorded on continuous EEG in the critical care setting. Epilepsy Behav 49:250–254. https://doi.org/10.1016/j.yebeh.2015.06.026CrossRefPubMed

27.

Koren J, Herta J, Draschtak S, Pötzl G, Pirker S, Fürbass F et al (2015) Prediction of rhythmic and periodic EEG patterns and seizures on continuous EEG with early epileptiform discharges. Epilepsy Behav 49:286–289. https://doi.org/10.1016/j.yebeh.2015.04.044CrossRefPubMed

28.

Naylor DE, Liu H, Wasterlain CG (2005) Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 25(34):7724–7733. https://doi.org/10.1523/JNEUROSCI.4944-04.2005CrossRefPubMedPubMedCentral

29.

Brigo F, Lattanzi S, Nardone R, Trinka E (2019) Intravenous brivaracetam in the treatment of status epilepticus: a systematic review. CNS Drugs 33(8):771–781. https://doi.org/10.1007/s40263-019-00652-0CrossRefPubMed

30.

Shorvon S, Ferlisi M (2011) The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 134(Pt 10):2802–2818. https://doi.org/10.1093/brain/awr215CrossRefPubMed

31.

Uppal P, Cardamone M, Lawson JA (2018) Outcomes of deviation from treatment guidelines in status epilepticus: a systematic review. Seizure 58:147–153. https://doi.org/10.1016/j.seizure.2018.04.005CrossRefPubMed

32.

Strzelczyk A, Steinig I, Willems LM, Reif PS, Senft C, Voss M et al (2017) Treatment of refractory and super-refractory status epilepticus with brivaracetam: a cohort study from two German university hospitals. Epilepsy Behav 70(Pt A):177–181. https://doi.org/10.1016/j.yebeh.2017.03.028CrossRefPubMed

33.

Strzelczyk A, Kay L, Bauer S, Immisch I, Klein KM, Knake S et al (2018) Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus. Epilepsia 59(8):1549–1556. https://doi.org/10.1111/epi.14476CrossRefPubMed

34.

Kalss G, Rohracher A, Leitinger M, Pilz G, Novak HF, Neuray C et al (2018) Intravenous brivaracetam in status epilepticus: a retrospective single-center study. Epilepsia 59(Suppl 2):228–233. https://doi.org/10.1111/epi.14486CrossRefPubMed

35.

Strzelczyk A, Knake S, Kälviäinen R, Santamarina E, Toledo M, Willig S et al (2019) Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain. Acta Neurol Scand 139(4):369–376. https://doi.org/10.1111/ane.13061CrossRefPubMedPubMedCentral

36.

Orlandi N, Bartolini E, Audenino D, ColettiMoja M, Urso L, d’Orsi G et al (2021) Intravenous brivaracetam in status epilepticus: a multicentric retrospective study in Italy. Seizure 86:70–76. https://doi.org/10.1016/j.seizure.2021.01.014CrossRefPubMed

Titel: Epidemiology, management and outcome of status epilepticus in adults: single-center Italian survey
verfasst von: Carlotta Mutti
Angelo Sansonetti
Giampiero Monti
Claudia Vener
Irene Florindo
Anna Elisabetta Vaudano
Irene Trippi
Giorgia Bernabè
Liborio Parrino
Lucia Zinno
Publikationsdatum: 06.09.2021
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 3/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05572-w

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

Predictivity of the clock drawing test in the acute phase of cerebrovascular diseases on cognitive decline at a 6-month neuropsychological evaluation

Early implementation of intended exercise improves quality of life in Parkinson’s disease patients

Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson’s disease

Clinical heterogeneity in patients with myoclonus associated to COVID-19

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?